Astrocyte

THE OTHER BLACKGUARDS - RISING TO THE CHALLENGE
Year
: 2017  |  Volume : 4  |  Issue : 1  |  Page : 67--74

Nontuberculous mycobacterial diseases: Current diagnosis and treatment


Shubham Sharma, Raja Dhar 
 Department of Pulmonology and Critical Care Medicine, Fortis Hospital, Kolkata, West Bengal, India

Correspondence Address:
Raja Dhar
Department of Pulmonology and Critical Care Medicine, Fortis Hospital, Kolkata, West Bengal
India

There has been an ever-expanding list of isolation of organisms in the genus Mycobacterium. Leprosy and tuberculosis are specific diseases caused by mycobacteria; there are now several other mycobacteria that cause human diseases and can be widely found in the environment. These other mycobacteria are called as nontuberculous mycobacteria (NTM) or mycobacteria other than tubercle bacilli (MOTT) or atypical mycobacteria. They cause various human infections in the lungs, lymph glands, skin, wounds, or bone. They may also produce disseminated disease, especially in the immunocompromised. Various molecular, biochemical, and chemical techniques have been developed for rapid identification of these species. While it might be difficult to treat these infections, with duration of treatment longer than that for tuberculosis or leprosy, many drugs such as rifampicin, rifabutin, ethambutol, clofazimine, amikacin, new generation quinolones, and macrolides effective against mycobacterial infections are available that can be used in appropriate combinations and dosage to treat the NTM.


How to cite this article:
Sharma S, Dhar R. Nontuberculous mycobacterial diseases: Current diagnosis and treatment.Astrocyte 2017;4:67-74


How to cite this URL:
Sharma S, Dhar R. Nontuberculous mycobacterial diseases: Current diagnosis and treatment. Astrocyte [serial online] 2017 [cited 2021 Dec 1 ];4:67-74
Available from: http://www.astrocyte.in/article.asp?issn=2349-0977;year=2017;volume=4;issue=1;spage=67;epage=74;aulast=Sharma;type=0